As the world learns more and more about the enigmatic nature of the pandemic that is COVID-19, emerging evidence shows that erratic blood clotting — or coagulopathy — often complicates severe COVID-19 cases.
Practicing Tai Chi proved effective in enhancing the psychological well-being of older adults (≥60 years) with cardiovascular disease (CVD), consequently improving their quality of life (QoL), a meta-analysis has shown.
A novel, sirolimus-eluting bioresorbable scaffold (BRS) has demonstrated potential in treating single coronary lesions, holding promise in vascular restoration therapy, the RENASCENT II* trial has shown.
Proactive treatment with high-dose intravenous (IV) iron reduces the risk for type 1 or classic myocardial infarction (MI), but not type 2 MI, in patients with chronic kidney disease (CKD) on dialysis, according to a prespecified secondary analysis of the PIVOTAL study.
Extended-duration thromboprophylaxis with low-dose rivaroxaban in at-risk medically ill patients discharged from the hospital significantly reduces fatal and major thromboembolic events, including symptomatic venous thromboembolism (VTE), myocardial infarction (MI), nonhaemorrhagic stroke, and cardiovascular (CV) death, with no significant increase in major bleeding, compared with placebo, a study has shown.
High neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios may be indicative of a failure to resolve left ventricular thrombosis (LVT) in postacute myocardial infarction (post-AMI) patients not receiving percutaneous coronary intervention (PCI), according to a new Singapore study.
Blood pressure (BP) control can be best achieved with a multilevel, multicomponent approach involving team-based care with physician- and non-physician-led interventions, as well as patient-level strategies, according to findings of a meta-analysis.
Not only are probiotics healthy for the gut, they may also be good for the waistline. A recent study shows that supplementation with the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 (Ba8145) improves anthropometric adiposity measures such as waist circumference, body mass index (BMI), and visceral fat area in abdominally obese individuals, particularly in women.